Autoimmune Retinopathies: A Report of 3 Cases

References

• Ohguro H, Yokoi Y, Ohguro I, et al. Clinical and immunological aspects of cancer-associated retinopathy. Am J Ophthalmol. 2004;137:1117–1119
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Vistica BP, Milam AH, et al. Recoverin associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol. 1998;126:230–237
   PubMed Web of Science ®Google Scholar
• Heckenlively JR, Ferreyra HA. Autoimmune retinopathy: a review and summary. Semin Immunopathol. 2008;30:127–134
   PubMed Web of Science ®Google Scholar
• Ling CPW, Pavesio C. Paraneoplastic syndromes associated with visual loss. Curr Opin Ophthalmol. 2003;14:426–432
   PubMedGoogle Scholar
• Heckenlively JR, Jordan BL, Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1999;127:565–573
   PubMed Web of Science ®Google Scholar
• Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arc Ophthalmol. 1987;105:372–375
   PubMedGoogle Scholar
• Adamus G, Aptsiauri N, Guy J, et al. The occurrence of serum autoantibodies against enolase in cancer associated retinopathy. Clin Immunol Immunopathol. 1996;78:120–129
   PubMedGoogle Scholar
• Ohguro H, Ogawa K, Nakagawa T. Recoverin and HSC 70 are found as autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1999;40:82–89
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Arai J, Shibuki H, et al. Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy. J Neuroimmunol. 2000;103:26–33
   PubMed Web of Science ®Google Scholar
• Eichen JG, Dalmau J, Demopoulos A, et al. The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy. J Neuroophthalmol. 2001;21:168–172
   PubMedGoogle Scholar
• Kornguth SE, Kalinke T, Grunwald GB, et al. Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res. 1986;46:2588–2595
   PubMed Web of Science ®Google Scholar
• Jacobson DM, Admus G. Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma. Am J Ophthalmol. 2001;131:806–808
   Google Scholar
• Abazari A, Allam SS, Adamus G, et al. Optical coherence tomography findings in autoimmune retinopathy. Am J Ophthalmol. 2012;153:750–756
   PubMed Web of Science ®Google Scholar
• Sawyer RA, Selhorst JB, Zimmerman LE, et al. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol. 1976;81:606–613
   PubMed Web of Science ®Google Scholar
• Keltner JL, Thirkill CE. Cancer-associated retinopathy versus recoverin-associated retinopathy. Am J Ophthalmol. 1998;126:296–302
   PubMed Web of Science ®Google Scholar
• Thirkill CE, Tait RC, Tyler NK, et al. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci. 1992;33:2768–2772
   PubMed Web of Science ®Google Scholar
• Adamus G, Guy J, Schmied JL, et al. Role of antirecoverin autoantibodies in cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34:2626–2633
   PubMed Web of Science ®Google Scholar
• Adamus G, Amundson D, Seigel GM, et al. Anti-enolase alpha auto-antibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells. J Autoimmun. 1998;11:671–677
   PubMed Web of Science ®Google Scholar
• Carboni G, Forma G, Bond AD, et al. Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss. Doc Ophthalmol. 2012;125:63–70
   PubMed Web of Science ®Google Scholar
• Radhakrishnan SS, Forma G, Carboni G, et al. Patterns of visual function loss in autoimmune neuro-retinopathy (AINR): psychophysical and electrophysiological findings [ARVO abstract]. Invest Ophthalmol Vis Sci. 2010;51. E-abstract 3547
   Google Scholar
• Arnol AC, Lee AG. Systemic disease and neuroophthalmology: annual update 2000 (part 1). J Neuroophthalmol. 2001;21:46–61
   Google Scholar
• Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol. 2003;48:12–38
   PubMed Web of Science ®Google Scholar
• Oyama Y, Burt RK, Thirkill C, et al. A case of autoimmune-related retinopathy and optic neuropathy syndrome treated by autologous nonmyeloablative hematopoietic stem cell transplantation. J Neuroophthalmol. 2009;29:43–49
   Google Scholar
• Adamus G, Brown L, Schiffman J, Iannaccone A. Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy. J Ophthal Inflamm Infect. 2011;1:111–121
   PubMedGoogle Scholar
• Keltner JL, Johnson CA, Spurr JO, et al. Baseline visual field profile of optic neuritis. Arc Ophthalmol. 1993;111:231–234
   PubMedGoogle Scholar
• Spaide RF, Koizumi H, Freund KB. Photoreceptor outer segment abnormalities as a cause of blind spot enlargement in acute zonal occult outer retinopathy-complex diseases. Am J Ophthalmol. 2008;146:111–120
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Imamura Y, Giovinazzo VJ, Spaide RF. Fundus autofluorescence and optical coherence tomographic findings in acute zonal occult outer retinopathy. Retina. 2010;30:1206–1216
   PubMed Web of Science ®Google Scholar
• Tunoda K, Fujinami K, Miyake Y. Selective abnormality of cone outer segment tip line in acute zonal occult outer retinopathy as observed by spectral-domain optical coherence tomography. Arch Ophthalmol. 2011;129:1099–1101
   Google Scholar
• Mkrtchyan M, Lujan BJ, Merino D, et al. Outer retinal structure in patients with acute zonal occult outer retinopathy. Am J Ophthalmol. 2012;153:757--768
   Google Scholar
• De Boer J, Berendschot TT, van der Does P, et al. Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol. 2006;141:616–621
   PubMed Web of Science ®Google Scholar
• Jain R, Ferrante P, Reddy GT. Clinical features and visual outcome of intermediate uveitis in children. Clin Exp Ophthalmol. 2005;33:22–25
   PubMed Web of Science ®Google Scholar
• Heckenlively JR, Solish AM, Chant SM, et al. Autoimmunity in hereditary retinal degenerations, II: clinical studies: antiretinal antibodies and fluorescein angiogram findings. Br J Ophthalmol. 1985;69:758–764
   PubMed Web of Science ®Google Scholar
• Kuchle M, Nguyen NX, Schalnus R. Quantification of disorders of the blood–aqueous humor barrier in retinitis pigmentosa, initial results. Klin Monbl Augenheilkd. 1994;204:211–216
   Google Scholar
• Newsome DA. Retinal fluorescein leakage in retinitis pigmentosa. Am J Ophthalmol. 1986;101:354–360
   PubMed Web of Science ®Google Scholar
• Ferreyra HA, Jayasundera T, Khan NW, et al. Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol. 2009;127:390–397
   PubMed Web of Science ®Google Scholar
• Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol. 1999;117:471–477
   PubMed Web of Science ®Google Scholar
• Klingele TG, Burde RM, Rappazzo JA, et al. Paraneoplastic retinopathy. J Clin Neuro-ophthalmol. 1984;4:239–245
   PubMedGoogle Scholar
• Shimazaki K, Jirawuthiworavong GV, Heckenlively JR. Frequency of anti-retinal antibodies in normal human serum. J Neuro-ophthalmol. 2008;28:5–11
   PubMed Web of Science ®Google Scholar
• Heckenlively JR, Fawzi AA, Oversier J, et al. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol. 2000;118:1525–1533
   PubMedGoogle Scholar
• Gass JD, Agarwal A, Scott IU. Acute zonal occult outer retinopathy: a long-term follow-up study. Am J Ophthalmol. 2002;134:329–339
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Morales DS, Sun XK, et al. Pattern of retinal dysfunction in acute zonal occult outer retinopathy. Ophthalmology. 1995;102:1187–1198
   PubMedGoogle Scholar